NO20090457L - Oksazolidon derivativer som PR modulatorer - Google Patents
Oksazolidon derivativer som PR modulatorerInfo
- Publication number
- NO20090457L NO20090457L NO20090457A NO20090457A NO20090457L NO 20090457 L NO20090457 L NO 20090457L NO 20090457 A NO20090457 A NO 20090457A NO 20090457 A NO20090457 A NO 20090457A NO 20090457 L NO20090457 L NO 20090457L
- Authority
- NO
- Norway
- Prior art keywords
- hormone
- compounds
- treatment
- modulators
- intake
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83789806P | 2006-08-15 | 2006-08-15 | |
| PCT/US2007/017931 WO2008021331A2 (en) | 2006-08-15 | 2007-08-13 | Oxazolidone derivatives as pr modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20090457L true NO20090457L (no) | 2009-04-27 |
Family
ID=39082681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20090457A NO20090457L (no) | 2006-08-15 | 2009-01-29 | Oksazolidon derivativer som PR modulatorer |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7618990B2 (es) |
| EP (1) | EP2054410A2 (es) |
| JP (1) | JP2010500409A (es) |
| KR (1) | KR20090039774A (es) |
| CN (1) | CN101501031B (es) |
| AR (1) | AR062327A1 (es) |
| AU (1) | AU2007284599B2 (es) |
| BR (1) | BRPI0716622A2 (es) |
| CA (1) | CA2659208A1 (es) |
| CR (1) | CR10617A (es) |
| GT (1) | GT200900032A (es) |
| IL (1) | IL196886A0 (es) |
| MX (1) | MX2009001698A (es) |
| NO (1) | NO20090457L (es) |
| NZ (1) | NZ574753A (es) |
| PE (1) | PE20070753A1 (es) |
| RU (1) | RU2009105113A (es) |
| SA (1) | SA07280440B1 (es) |
| SV (1) | SV2009003168A (es) |
| TW (1) | TW200815428A (es) |
| WO (1) | WO2008021331A2 (es) |
| ZA (1) | ZA200901055B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008112495A1 (en) * | 2007-03-09 | 2008-09-18 | Wyeth | Synthesis and characterization of polymorph form iii of 4-(2,(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile |
| PE20081803A1 (es) * | 2007-03-09 | 2008-12-11 | Wyeth Corp | Sintesis y caracterizacion de la forma ii polimorfica de 4-(2-(4,4-dimetil-2-oxooxazolidin-3-il)tiazol-4-il)benzonitrilo |
| CN101525310B (zh) * | 2009-04-21 | 2019-04-16 | 大连九信精细化工有限公司 | 1-苯甲酰基-3-(2-羟基-1，1-二甲基乙基)硫脲的合成方法 |
| AU2011312490B2 (en) * | 2010-09-28 | 2015-06-25 | Radius Pharmaceuticals, Inc. | Selective androgen receptor modulators |
| US9120818B2 (en) * | 2010-12-14 | 2015-09-01 | Merck Sharp & Dohme Corp. | Process and intermediates for preparing macrolactams |
| JP6663866B2 (ja) * | 2014-07-03 | 2020-03-13 | セルジーン クオンティセル リサーチ，インク． | リジン特異的なデメチラーゼ−１の阻害剤 |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670338A1 (de) | 1966-03-14 | 1972-08-10 | Heyden Chem Fab | Verfahren zur Herstellung von antimikrobiell wirksamen Nitrofuranderivaten |
| US3493565A (en) | 1966-03-14 | 1970-02-03 | Squibb & Sons Inc | 3-amino-5-(nitrofuryl)-1,2,4-oxadiazole derivatives |
| NL6809997A (es) * | 1967-08-04 | 1969-02-06 | ||
| GB1224995A (en) | 1968-09-20 | 1971-03-10 | Delalande Sa | New 5-propargyloxymethyl-2-substituted oxazolidinones and their process of preparation |
| US4293558A (en) * | 1975-10-28 | 1981-10-06 | Eli Lilly And Company | Antiviral thiazolinyl benzimidazoles and derivatives |
| CA1076582A (en) * | 1975-10-28 | 1980-04-29 | Charles J. Paget | Antiviral thiazolinyl or thiazinyl ketobenzimidazoles |
| US4008243A (en) * | 1975-11-19 | 1977-02-15 | Eli Lilly And Company | Antiviral thiazolinyl or thiazinyl benzimidazole esters |
| US4268679A (en) * | 1980-02-19 | 1981-05-19 | Ppg Industries, Inc. | 3-[5- or 3-Substituted-5- or 3-isoxazolyl]-1-allyl or alkyl-4-substituted-5-substituted or unsubstituted-2-imidazolidinones |
| US4426527A (en) * | 1982-02-12 | 1984-01-17 | Ppg Industries, Inc. | 3-[5- Or 3-substituted-1,2,4-oxadiazol-3- or -5-yl]-1-substituted-4-substituted-5-substituted or unsubstituted-2-imidazolidinones |
| DE3227329A1 (de) | 1982-07-22 | 1984-01-26 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von 2-n,n-disubstituierten aminothiazolen |
| US4756744A (en) * | 1985-06-24 | 1988-07-12 | Ppg Industries, Inc. | Herbicidally active 4-aminoalkylamino-3-isoxazolyl-2-imidazolidinone derivatives |
| DE3723797A1 (de) | 1987-07-18 | 1989-01-26 | Merck Patent Gmbh | Oxazolidinone |
| IE913855A1 (en) | 1990-11-06 | 1992-05-22 | Smithkline Beecham Corp | Imidazolidinone compounds |
| DE69132944T2 (de) | 1990-11-30 | 2002-11-21 | Otsuka Pharmaceutical Co., Ltd. | Azolederivate als Inhibitor von Superoxide-Radikalen |
| DE4335876A1 (de) * | 1993-10-17 | 1995-04-20 | Schering Ag | Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen |
| JPH07149745A (ja) | 1993-11-30 | 1995-06-13 | Hisamitsu Pharmaceut Co Inc | 新規な２−アミノチアゾール誘導体 |
| WO1995015955A1 (de) | 1993-12-06 | 1995-06-15 | Basf Aktiengesellschaft | 2,4-diaminothiazole und ihre herstellung |
| DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| DE19540027A1 (de) | 1995-10-27 | 1997-04-30 | Gruenenthal Gmbh | Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe |
| US5714607A (en) * | 1995-12-01 | 1998-02-03 | American Cyanamid Company | Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide |
| DE19601264A1 (de) * | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
| DE19649095A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue Heteroaryl-Oxazolidinone |
| DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
| HRP970049A2 (en) | 1996-02-06 | 1998-04-30 | Bayer Ag | New heteroaryl oxazolidinones |
| US6251897B1 (en) | 1996-07-31 | 2001-06-26 | Nikken Chemicals Co., Ltd | 6-phenyltetrahydro-1,3-oxazin-2-one derivative and pharmaceutical composition containing the same |
| US5972372A (en) * | 1996-07-31 | 1999-10-26 | The Population Council, Inc. | Intravaginal rings with insertable drug-containing core |
| US5819742A (en) * | 1996-11-06 | 1998-10-13 | Family Health International | Vaginal device for preventing conception or the transmission of sexually transmitted diseases, or both |
| DE19732928C2 (de) | 1997-07-31 | 2000-05-18 | Gruenenthal Gmbh | Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel |
| AU9648098A (en) * | 1997-10-27 | 1999-05-17 | Takeda Chemical Industries Ltd. | Adenosine a3 receptor antagonists |
| US6562844B2 (en) * | 1998-01-23 | 2003-05-13 | Pharmacia & Upjohn Company | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| BR9907183A (pt) * | 1998-01-23 | 2003-06-10 | Versicor Inc | Colet neas combinatórias de oxazolidinona, composições e processos de preparação |
| AU3289299A (en) | 1998-02-19 | 1999-09-06 | Tularik Inc. | Antiviral agents |
| JP2001261652A (ja) | 2000-03-21 | 2001-09-26 | Suntory Ltd | 二置換イミノヘテロサイクリック化合物 |
| WO2001074811A2 (en) | 2000-03-30 | 2001-10-11 | Takeda Chemical Industries, Ltd. | Substituted 1,3-thiazole compounds, their production and use |
| GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| DE10034622A1 (de) | 2000-07-17 | 2002-01-31 | Bayer Ag | Substituierte Imidazol-Derivate und deren Verwendung zur Herstellung von Arzneimitteln |
| DE10034623A1 (de) | 2000-07-17 | 2002-01-31 | Bayer Ag | Heterocyclisch substituierte Pyridine als Cytokin-Inhibitoren |
| DE10034628A1 (de) | 2000-07-17 | 2002-01-31 | Bayer Ag | Pyridinhaltige Oxazolidinone als Cytokin-Inhibitoren |
| US20020115669A1 (en) * | 2000-08-31 | 2002-08-22 | Wiedeman Paul E. | Oxazolidinone chemotherapeutic agents |
| FR2823209B1 (fr) | 2001-04-04 | 2003-12-12 | Fournier Lab Sa | Nouvelles thiohydantoines et leur utilisation en therapeutique |
| GB0118407D0 (en) | 2001-07-27 | 2001-09-19 | Cipla Ltd | Oxazolidinone derivatives as antibacterial agents |
| KR100437972B1 (ko) * | 2001-10-27 | 2004-07-02 | 한국과학기술연구원 | 피롤리디논 유도체, 이의 제조 방법 및 이를 포함하는제약 조성물 |
| US7119111B2 (en) | 2002-05-29 | 2006-10-10 | Amgen, Inc. | 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| BR0313160A (pt) | 2002-08-08 | 2005-07-12 | Smithkline Beecham Corp | Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto |
| TWI324596B (en) * | 2002-08-26 | 2010-05-11 | Nat Health Research Institutes | Imidazolamino compounds |
| JP2006504679A (ja) | 2002-08-28 | 2006-02-09 | メルク フロスト カナダ アンド カンパニー | 緑内障の治療においてｅｐ４受容体作動薬として使用するためのオキサゾリジン−２−オンおよびチアゾリジン−２−オン誘導体 |
| US20040167192A1 (en) * | 2003-01-16 | 2004-08-26 | David Solow-Cordero | Methods of treating conditions associated with an Edg-7 receptor |
| US7169797B2 (en) * | 2003-02-14 | 2007-01-30 | Abbott Laboratories | Protein-tyrosine phosphatase inhibitors and uses thereof |
| US20040235834A1 (en) | 2003-03-25 | 2004-11-25 | Farmer Luc J. | Thiazoles useful as inhibitors of protein kinases |
| CN100387594C (zh) | 2003-04-03 | 2008-05-14 | 麦克公司 | 二芳基取代的吡唑类代谢型谷氨酸受体-5调节剂 |
| CN1829721A (zh) | 2003-07-08 | 2006-09-06 | 阿斯利康(瑞典)有限公司 | 对α7烟碱乙酰胆碱受体具有亲和力的螺[1－氮杂二环[2.2.2]辛烷－3,5’－噁唑烷]－2’－酮衍生物 |
-
2007
- 2007-07-31 TW TW096127981A patent/TW200815428A/zh unknown
- 2007-08-10 AR ARP070103552A patent/AR062327A1/es not_active Application Discontinuation
- 2007-08-13 CA CA002659208A patent/CA2659208A1/en not_active Abandoned
- 2007-08-13 KR KR1020097002974A patent/KR20090039774A/ko not_active Application Discontinuation
- 2007-08-13 CN CN2007800302230A patent/CN101501031B/zh not_active Expired - Fee Related
- 2007-08-13 WO PCT/US2007/017931 patent/WO2008021331A2/en active Application Filing
- 2007-08-13 EP EP07836789A patent/EP2054410A2/en not_active Withdrawn
- 2007-08-13 NZ NZ574753A patent/NZ574753A/en not_active IP Right Cessation
- 2007-08-13 JP JP2009524654A patent/JP2010500409A/ja active Pending
- 2007-08-13 AU AU2007284599A patent/AU2007284599B2/en not_active Ceased
- 2007-08-13 RU RU2009105113/04A patent/RU2009105113A/ru not_active Application Discontinuation
- 2007-08-13 BR BRPI0716622-2A patent/BRPI0716622A2/pt not_active IP Right Cessation
- 2007-08-13 MX MX2009001698A patent/MX2009001698A/es active IP Right Grant
- 2007-08-13 US US11/891,748 patent/US7618990B2/en not_active Expired - Fee Related
- 2007-08-14 SA SA07280440A patent/SA07280440B1/ar unknown
- 2007-08-15 PE PE2007001100A patent/PE20070753A1/es not_active Application Discontinuation
-
2009
- 2009-01-29 NO NO20090457A patent/NO20090457L/no not_active Application Discontinuation
- 2009-02-03 IL IL196886A patent/IL196886A0/en unknown
- 2009-02-12 GT GT200900032A patent/GT200900032A/es unknown
- 2009-02-12 SV SV2009003168A patent/SV2009003168A/es unknown
- 2009-02-13 ZA ZA200901055A patent/ZA200901055B/xx unknown
- 2009-02-13 CR CR10617A patent/CR10617A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7618990B2 (en) | 2009-11-17 |
| KR20090039774A (ko) | 2009-04-22 |
| SA07280440B1 (ar) | 2010-10-20 |
| PE20070753A1 (es) | 2008-08-14 |
| IL196886A0 (en) | 2009-11-18 |
| GT200900032A (es) | 2011-03-29 |
| AU2007284599B2 (en) | 2011-07-21 |
| RU2009105113A (ru) | 2010-09-27 |
| AU2007284599A1 (en) | 2008-02-21 |
| EP2054410A2 (en) | 2009-05-06 |
| CN101501031B (zh) | 2012-02-01 |
| WO2008021331A3 (en) | 2008-05-22 |
| TW200815428A (en) | 2008-04-01 |
| US20080045556A1 (en) | 2008-02-21 |
| JP2010500409A (ja) | 2010-01-07 |
| ZA200901055B (en) | 2009-12-30 |
| CA2659208A1 (en) | 2008-02-21 |
| WO2008021331A2 (en) | 2008-02-21 |
| AR062327A1 (es) | 2008-10-29 |
| CR10617A (es) | 2009-03-12 |
| CN101501031A (zh) | 2009-08-05 |
| NZ574753A (en) | 2011-04-29 |
| MX2009001698A (es) | 2009-02-25 |
| SV2009003168A (es) | 2010-01-14 |
| BRPI0716622A2 (pt) | 2013-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20090457L (no) | Oksazolidon derivativer som PR modulatorer | |
| WO2008021339A3 (en) | Pyrrolidine and related derivatives useful as pr modulators | |
| NO20084364L (no) | Azetidin derivater som G-protein koblet reseptor (GPR119) agonister | |
| NO20075082L (no) | Pyridin-3-karboksamidderivater som CB1-inversagonister | |
| NO20084307L (no) | Heterocykliske GPCR agonister | |
| NO20082136L (no) | 1,5-substituerte indol-2-yl-amidderivater | |
| ATE526318T1 (de) | Farnesoid-x-rezeptor-agonisten | |
| EA200701324A1 (ru) | Соединения пиридина для лечения заболеваний, опосредованных действием простагландина | |
| DK1807072T3 (da) | Cycloalkyllactamderivater som inhibitorer af 11-beta-hydroxysteroid-dehydrogenase 1 | |
| NO20080670L (no) | Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister | |
| TW200806311A (en) | Neuropeptide-2 receptor-agonists | |
| DK1807434T3 (da) | Thienopyridiner som allosteriske potentiatorer af M4- muscarinreceptoren | |
| NO20073664L (no) | Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet | |
| NO20076134L (no) | Benzamidderivater og anvendelser derav | |
| NO20071138L (no) | Piperazinderivater som er nyttige for behandling av gastrointestinallidelser | |
| GEP20156348B (en) | Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators | |
| DE602006009095D1 (en) | Diacylglycerol-acyltransferase-hemmer | |
| TW200612936A (en) | Indole derivatives | |
| NO20070588L (no) | Piperidinderivater som NK1-antagonister. | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| NO20052730L (no) | Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser | |
| ATE466842T1 (de) | 3-substituierte pyridinderivate als h3- antagonisten | |
| NO20063576L (no) | 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes | |
| MX2007007027A (es) | Derivados piperazinilpiridina como agentes anti-obesidad. | |
| NO20061981L (no) | Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |